A Study on the Systemic Inflammatory Index (SII) and Related Factors in Patients with Malignant Otitis Externa

Year 2024, Volume: 8 Issue: 3, 759 - 764, 30.09.2024

Asuman Feda Bayrak , Muhammed Mirza Doğan , Baturalp Çetin

https://doi.org/10.30621/jbachs.1550234

Abstract

Purpose: This study aims to investigate the relationship between systemic inflammatory index and various clinical and microbiological factors in patients with malignant otitis externa (MOE).
Materials and Methods: In this retrospective study, patients diagnosed with MOE and treated between January 2017 and March 2023 were examined. The data include clinical evaluations, laboratory tests, and imaging results. All patients underwent computed tomography of the temporal bone, and MOE was staged according to Tengku's radiological classification .SII was calculated using neutrophil, platelet, and lymphocyte counts.
Results: 11 patients were examined retrospectively, including 8 males (72.7%) and 3 females (27.3%). The mean age of the patients was 72.3±7.5 years. Comorbidities such as Diabetes Mellitus (DM) and Chronic Kidney Disease (CKD) were associated with higher SII values. CT phases and cranial nerve involvement were also related to high SII values. Microbiological analyses showed that pathogens such as Pseudomonas aeruginosa and Candida tropicalis were associated with high SII values.
Conclusion: SII is an important biomarker in evaluating the prognosis and treatment response in MOE. Early diagnosis, a multidisciplinary approach, and personalized treatment strategies are critical in managing MOE. Further studies involving larger patient groups will contribute to validating these relationships and improving treatment processes.

Keywords

Malignant otitis externa, systemic inflammatory index, diabetes mellitus, cranial nerve involvement, skull base osteomyelitis, CT phases

References

• Treviño González JL, Reyes Suárez LL, Hernández de León JE. Malignant otitis externa: An updated review. Am J Otolaryngol 2021;42(2):102894.
• Karaman E, Yilmaz M, Ibrahimov M, Haciyev Y, Enver O. Malignant otitis externa. J Craniofac Surg 2012;23(6):1748-51.
• Chen CN, Chen YS, Yeh TH, Hsu CJ, Tseng FY. Outcomes of malignant external otitis: survival vs mortality. Acta Otolaryngol 2010;130(1):89-94.
• Afzalzadeh M. Antimicrobial agents in malignant otitis externa: A systematic review. Rev Clin Med 2021;8(4):145-159.
• Hollis S, Evans K. Management of malignant (necrotising) otitis externa. J Laryngol Otol 2011;125(12):1212-7.
• Kamalden TMIT and Misron K. A 10-year review of malignant otitis externa: A new insight. Eur Arch Otorhinolaryngol 2022;279(6):2837-2844.
• Sudhoff H, Rajagopal S, Mani N, Moumoulidis I, Axon PR, Moffat D. Usefulness of CT scans in malignant external otitis: effective tool for the diagnosis, but of limited value in predicting outcome. Eur Arch Otorhinolaryngol 2008;265(1):53-6.
• Dziedzic EA, Gąsior JS, Tuzimek A, et all. Investigation of the Associations of Novel Inflammatory Biomarkers-Systemic Inflammatory Index (SII) and Systemic Inflammatory Response Index (SIRI)-With the Severity of Coronary Artery Disease and Acute Coronary Syndrome Occurrence. Int J Mol Sci 2022;23(17):9553.
• Islam MM, Satici MO, Eroglu SE. Unraveling the clinical significance and prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammation response index, and delta neutrophil index: An extensive literature review. Turk J Emerg Med 2024;24(1):8-19.
• Templeton AJ, McNamara MG, Šeruga B, et all. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 2014;106(6):dju124.
• Stevens SM, Lambert PR, Baker AB, Meyer TA. Malignant Otitis Externa: A Novel Stratification Protocol for Predicting Treatment Outcomes. Otol Neurotol 2015;36(9):1492-8.
• Sideris G, Latzonis J, Avgeri C, Malamas V, Delides A, Nikolopoulos T. A Different Era for Malignant Otitis Externa: The Non-Diabetic and Non-Immunocompromised Patients. J Int Adv Otol 2022;18(1):20-24.
• Arsovic N, Radivojevic N, Jesic S, Babac S, Cvorovic L, Dudvarski Z. Malignant Otitis Externa: Causes for Various Treatment Responses. J Int Adv Otol 2020;16(1):98-103.
• Özer F, Pamuk AE, Atay G, Parlak Ş, Yücel T. Skull base osteomyelitis: Comprehensive analysis and a new clinicoradiological classification system. Auris Nasus Larynx 2021;48(5):999-1006.
• Long DA, Koyfman A, Long B. An emergency medicine-focused review of malignant otitis externa. Am J Emerg Med 2020;38(8):1671-1678.
• Foster, T. Orji, James, O. Akpeh, Onyinyechi, C. Ukaegbe. Malignant otitis externa: An assessment of emerging pathogens and the prognostic factors. International Journal of Medicine and Medical Sciences 2017;9(7):86-91.
• Freeman MH, Perkins EL, Tawfik KO, O'Malley MR, Labadie RF, Haynes DS, Bennett ML. Facial Paralysis in Skull Base Osteomyelitis - Comparison of Surgical and Nonsurgical Management. Laryngoscope 2023;133(1):179-183.
• Marina S, Goutham MK, Rajeshwary A, Vadisha B, Devika T. A retrospective review of 14 cases of malignant otitis externa. J Otol 2019;14(2):63-66.
• Yigider AP, Ovunc O, Arslan E, Sunter AV, Cermik TF, Yigit O. Malignant Otitis Externa: How to Monitor the Disease in Outcome Estimation? Medeni Med J 2021;36(1):23-29.